India MCA Insolvency Liquidation Filings — October 08, 2026

NCLT admitted a Section 9 CIRP petition on 7 October 2026 concerning an alleged operational debt of only ₹2.79 crore, but the company filed an NCLAT appeal on 8 October and has a hearing on 9 October; the appeal outcome is the decisive near-term catalyst

NCLAT granted interim relief allowing the board to increase authorised capital, conduct a rights issue, and restore MCA21 digital signatures while CIRP remains suspended; this preserves a financing-led restructuring route [BULLISH—EXECUTION DEPENDENT]

A Master Restructuring Agreement was signed on 5 October 2026 with the principal financial creditor holding approximately 97% of CoC voting rights, providing unusually concentrated creditor alignment and a target to complete the process by 31 December 2026

The revised preferential-allotment proposal covers 1.20 crore equity shares, approximately 94.81% of post-allotment capital, signalling a potentially transformative equity infusion but also a substantial ownership and control reset

CoC e-voting rejected both proposed Resolution Professional appointments at the fifth CoC meeting, indicating that creditors remain unable to align on process leadership

NCLT Ahmedabad sanctioned the amalgamation of two wholly owned subsidiaries into the listed parent on 8 October 2026; because the transferors are wholly owned subsidiaries, the transaction is structurally simpler than a third-party acquisition and may support group simplification

The NCLT-directed merger of wholly owned CIE Aluminium Casting India is proceeding without issuance of new shares and without adverse alteration of creditor rights, reducing dilution and consideration risk [BULLISH—LOW MATERIALITY]

NCLT corrected the named IRP in its 5 August 2026 resolution-plan order without changing any plan term, confirming that the approved Resolution Plan remains substantively intact

The 13th CoC meeting was rescheduled by four days, from 8 October to 12 October 2026, suggesting the process remains active but does not yet provide evidence of a resolution-plan breakthrough

None of the 8 filings reports YoY or QoQ revenue, EBITDA, margin, debt-to-equity, ROE, dividend, buyback, insider-trading, or guidance changes; investment decisions should therefore be driven by legal-process milestones rather than conventional earnings momentum

NCLT admitted insolvency proceedings under Section 9 on 7 October 2026; until NCLAT grants relief, the admission creates a material legal, operational, and reputational overhang despite the relatively small alleged debt of ₹2.79 crore

The NCLAT hearing is scheduled for 9 October 2026, leaving an immediate binary event risk and limited time for the market to assess whether the CIRP admission is stayed, reversed, or allowed to proceed

Both candidates proposed as Resolution Professional were rejected by the CoC after e-voting ended on 7 October 2026, potentially delaying the resolution process and increasing value deterioration, professional costs, and liquidation risk

The rights issue must commence on 9 October and conclude by 31 December 2026; failure to secure subscriptions, complete corporate actions, or implement the restructuring agreement could leave the company exposed despite interim legal relief

CIRP was initiated on 17 April 2026 and the admission order was suspended by NCLAT on 30 April 2026; the restructuring remains dependent on ongoing appellate and creditor-process outcomes, with the matter next listed on 16 November 2026

The proposed allotment of 1.20 crore shares would constitute approximately 94.81% of post-allotment capital, creating extreme dilution for existing shareholders and a potential change in control

The company has been under CIRP since the NCLT Mumbai order dated 1 February 2024, yet the 13th CoC meeting was only rescheduled rather than converted into a disclosed resolution milestone, highlighting duration and recovery uncertainty

The amalgamation is not effective merely on pronouncement of the NCLT order; the certified order must still be filed with the Registrar of Companies, Ahmedabad, creating a remaining legal-completion condition

Although the resolution plan was unchanged, the need to rectify the identity of the IRP in the original approval order illustrates documentation and execution-control risk in a distressed-company process

The combination of a Master Restructuring Agreement signed with a creditor holding approximately 97% of CoC voting rights and NCLAT permission to undertake a rights issue creates a defined turnaround pathway through 31 December 2026; investors should monitor subscription levels and creditor implementation

The next listing on 16 November 2026 could clarify the durability of the CIRP suspension and the company's authority to complete the rights issue and related corporate actions

A successful appeal or stay on 9 October could rapidly remove the immediate CIRP overhang associated with the ₹2.79 crore claim; the opportunity is event-driven but highly binary and unsuitable for unhedged risk-taking

If the proposed preferential allotment receives BSE in-principle listing approval and the funds are successfully deployed, the transaction could recapitalise the company and advance the restructuring plan first considered on 10 July 2025

Completion of the court-sanctioned merger of Kilburn Chemicals and Meghmani Crop Nutrition into the parent could reduce subsidiary complexity and generate operational or administrative synergies without the complications of a third-party acquisition

The merger of CIEALCAST involves no new share issuance and cancellation of the wholly owned subsidiary's share capital, offering a low-dilution route to operational efficiencies and synergies

The rectification order confirms that the approved Resolution Plan and its terms remain unchanged, allowing investors to focus on implementation milestones rather than renegotiation risk

The rescheduled 13th CoC meeting on 12 October 2026 provides a near-term opportunity to identify whether creditors move from procedural scheduling toward a resolution-plan, voting, or other substantive process update

All 8 filings are driven primarily by NCLT/NCLAT, CoC, rights-issue, merger, or resolution-plan milestones; no filing provides sufficient operating data to support an earnings-led cross-company ranking.

BGR Energy has a principal financial creditor with approximately 97% of CoC voting rights and a signed restructuring agreement, whereas Astron Paper faces rejection of both proposed RP candidates; concentrated alignment appears materially more constructive than procedural deadlock.

BGR Energy's rights issue and Shree Rajeshwaranand Paper Mills' proposed preferential allotment demonstrate the use of fresh equity or equity-linked recapitalisation to address stressed balance sheets, but both carry significant execution and dilution risk.

Polycab's CIRP admission relates to an alleged operational debt of ₹2.79 crore, underscoring that the legal significance of an IBC admission can far exceed the absolute amount in dispute.

Meghmani Organics and CIE Automotive India involve amalgamations of wholly owned subsidiaries, with no disclosed creditor impairment or third-party acquisition consideration; these should not be interpreted as distressed insolvency events.

SKIL Infrastructure has been in CIRP since 1 February 2024 and is only at its 13th CoC meeting, while Astron faces RP-selection failure and KSS required an order correction; investors should treat timelines and documentation as material value drivers.

Monitor the 9 October 2026 hearing for a stay, reversal, or continuation of the CIRP admission relating to the ₹2.79 crore alleged operational debt.

The rights-issue process is required to start on 9 October 2026; monitor pricing, entitlement terms, subscription commitments, and evidence of funding adequacy.

The postponed meeting is scheduled for 12 October 2026 at 12:00 PM IST; monitor for a resolution-plan update, RP action, or further postponement.

The matter is next listed on 16 November 2026; assess whether the CIRP suspension and board-authorised restructuring actions remain protected.

The Master Restructuring Agreement and rights-issue-related process are targeted for completion by 31 December 2026; monitor slippage, creditor consent, and allotment completion.

Track the company's application for in-principle listing approval for the revised proposed-allottee list and the final terms of the 1.20 crore-share preferential allotment.

Monitor the next CoC action after both proposed Resolution Professional appointments were rejected on 7 October 2026, including whether a fresh candidate is proposed or process timelines deteriorate.

Monitor filing of the certified NCLT orders with the relevant Registrar of Companies and subsequent effective-date disclosures; these are completion conditions for the respective amalgamations.